Injectable microfoam containing a sclerosing agent

Details Injectable microfoam containing a sclerosing agent Injectable microfoam containing a sclerosing agent

2004-09-15

2009-02-17

Ghali, Isis (Department: 1615)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Implant or insert

C424S422000, C424S484000, C424S489000, C514S706000, C514S708000, C514S709000, C514S945000

Reissue Patent

active

RE040640

ABSTRACT:
Injectable microfoam for scleroteraphy. The sclerotherapy of varices is based on the injection of liquid substances capable of suppressing them. The present invention relates to the preparation of sclerosing substances in the form of a microfoam. The microfoam is prepared with sclerosing agents, and is then injected in the vein to be treated, so that the microfoam displaces the blood contained in the vein and provides for the contact of the sclerosing agent with the vascular endothelium, with a predetermined known concentration and during a controllable time.

REFERENCES:
patent: 3698453 (1972-10-01), Morane et al.
patent: 3955720 (1976-05-01), Malone
patent: 3970219 (1976-07-01), Spitzer et al.
patent: 4019657 (1977-04-01), Spitzer et al.
patent: 4040420 (1977-08-01), Speer
patent: 4127131 (1978-11-01), Vaillancourt
patent: 4276885 (1981-07-01), Tickner et al.
patent: 4292972 (1981-10-01), Pawelchak et al.
patent: 4466442 (1984-08-01), Hilmann et al.
patent: 4718433 (1988-01-01), Feinstein
patent: 5048750 (1991-09-01), Tobler
patent: 5064103 (1991-11-01), Bennett
patent: 5084011 (1992-01-01), Grady
patent: 5141738 (1992-08-01), Rasor et al.
patent: 5542935 (1996-08-01), Unger et al.
patent: 5623085 (1997-04-01), Gebhard et al.
patent: 5656200 (1997-08-01), Boettcher et al.
patent: 5676962 (1997-10-01), Garrido et al.
patent: 5902225 (1999-05-01), Monson
patent: 6561237 (2003-05-01), Brass et al.
patent: 6572873 (2003-06-01), Osman et al.
patent: 2003/0082243 (2003-05-01), Harman et al.
patent: 2004/0101480 (2004-05-01), Osman et al.
patent: 1 232 837 (1988-02-01), None
patent: 3417182 (1989-01-01), None
patent: 0 054 728 (1982-06-01), None
patent: 0 077 752 (1983-04-01), None
patent: 0 123 235 (1984-10-01), None
patent: 0 131 540 (1985-01-01), None
patent: 0 217 582 (1987-04-01), None
patent: 0 324 938 (1989-07-01), None
patent: 0 359 246 (1990-03-01), None
patent: 0 656 203 (1995-06-01), None
patent: 0 997 396 (2000-05-01), None
patent: 2 672 038 (1992-07-01), None
patent: 2 775 436 (1999-09-01), None
patent: WO 92/05806 (1992-04-01), None
patent: 94/21384 (1994-09-01), None
patent: WO 95/00120 (1995-01-01), None
patent: WO 96/25194 (1996-08-01), None
patent: WO 99/43371 (1999-09-01), None
patent: WO 00/24649 (2000-05-01), None
patent: WO 00/66274 (2000-11-01), None
patent: WO 00 72821 (2000-12-01), None
German Nullity Action Complaint filed Jul. 27, 2001 and translation into English.
German Nullity Action First Brief filed Dec. 3, 2001 and translation into English.
German Nullity Action Supplemental Brief filed Dec. 31, 2002 and translation into English.
German Nullity Action Kreusler Brief filed Jan. 27, 2003 and translation into English.
German Nullity Action Decision by German Court in English dated Feb. 4, 2003.
German Nullity Action English Translation of the Substantiation of Appeal to the Federal Court of Justice on Sep. 26, 2003.
German Nullity Action English Translation of the Reply to appeal dated Feb. 12, 2004.
K1—Von P. Flöckiger, “Nicht-operative retrograde Varicenverödung mit Varsylschaum”, Schweizerische Medizinische Wochenschrift, No. 48, pp. 1368-1370, (1956) with English translation.
K2—H. Mayer et al., “On the aetiology and treatment of varices of the lower extremities”, Angiology, Chirurgische Praxis, pp. 521-528, (1957) with English translation.
K3—Meyer's Encyclopedia, 5thEdition, vol. 15, pp. 386 (1895) with English translation.
K5—Dr. Med. Jo{umlaut over (z)}e Baridevic; “Varicosclerozation in Phlebological Practice”, The Journal for Doctors, in Clinic and Practice; XXI Volume No. 3, pp. 126-136; Jan. 11, 1989, and translation into English.
K6—W. Gillesberger; “The Equipment of the Dermatologist Working in the Field of Phlebology”, the Journal for Skin Diseases; vol. 44 (18), pp. 669-674; 1969 and translation into English.
K7—Dr. E. Lunkenhelmer; letter to Chem. Fabrik Kreussler & Co.; Mar. 20, 1967 and translation into English.
K8—Gianni Belcaro; “Mirco-sclerotherapy”; Sclerotherapy in Venous Disease; pp. 89-95; 2002.
K9—M. Schadeck; “Ultrasound-controlled Sclerotherapy of the Great Saphenous Veins”; Phlébologie; vol. 46, No. 4, pp. 673-682, 1993 and translation into English.
K10—E. Rabe et al.; “Guidelines to Sclerosing Treatment of Varicose Veins”; Leitlinien der DGP, Phlebologie; vol. 6, pp. 154-158; 2001 and translation into English.
K12—K. Sigg, “Newer Aspects of the Techinque of Treating Varicosities”, Therapeutishce Umschau, vol. 6, pp. 127-134, 1949 and translation into English.
K13—M. Schadeck; “Duplex Controlled Sclerosing Treatment of the Great Saphenous Vein”; Phlebol; vol. 25, pp. 78-92; 1996 and translation into English.
K14—R. Rowden-Foote; “Varicose Veins Hemorrhoids Other Conditions—Their Treatment by Injection”; London, H.K. Lewis & Co. Ltd.; pp. 13-45, 106-119; 1944.
K15—A. Rae; “The Treatment of Varicose Veins with Etamolin Foam”; Acta Dermato-Venereologica; vol. 39, pp. 428-432, 1959.
K16—E.J. Orbach et al.; “The Thrombogenic Property of Foam of a Synthetic Anionic Detergent (Sodium Tetradecyl Sulfate N.N.R.)”, Angiol 1, pp. 237-243; 1950.
K17—M.D.H.-D. Bock; “Varicosis and its Therapy”, Arzttiche Praxis; XIX Volume, No. 60, pp. 2146-2148; Jul. 29, 1967 and translation into English.
K18—O. Henschel;“Die Varizenverördening—Verordungstherapie mit Aethoxysklerol—Kreussler”; p. 22; 1968 and translation into English.
K21—J. Orbach, “Sclerotherapy of Varicose Veins”, American Journal of Surgery, vol. LXVI, No. 3, pp. 362-366, Dec. 1944.
K22—J.R. Cabrera Garrido et al., “Extending the Limits of Sclerotherapy: New Sclerosing Products”, Phlépp;pgoe, vol. 50, No. 2, pp. 181-188;997.
K23—J. Cabrera; “Application Techniques for Sclerosant in Micro-Foam Form”; pp. 39-44.
K24—Video (VHS) tape of Compression Sclerotherapy, H.R., Bernbach, M.D. and English Translation of the Documentation Accompanying the Video K24; pp. 1-16.
K25—Dr. J.C. Wollmann et al.; Evaluation of the Test; Kreussler Pharma; pp. 17-28, Jan. 29, 2003.
DVD #1 and #2 containing video clips shown during interview of Jan. 7, 2004.
Written commentary tracking the DVDs submitted with Supplemental Information Disclosure Statement of Mar. 24, 2004.
Meyer's Encyclopedia, 5thEdition, 1895, vol. 15, pp. 386.
R. Bayeux, “Comparative Resistance of Dog and Rabbit to Intravenous Injection of Oxygen”, Compt. Rend. vol. 156, pp. 1329-1331, 1913, with Abstract in English.
F.W. Tunnicliffe et al., “The Intravenous Injection of Oxygen Gas as a Therapeutic Measure”, Lancet, vol. II, pp. 321-323, 1916, with Abstract in English.
G. Galata, “Intravenous Injection of Oxygen in Dogs”, Archivio di Fisiologia, vol. 21, pp. 331-350, 1923, with Abstract in English.
L. Moszkowiez, “Treatment of Varicose Veins with Sugar Injections, combined with vein ligation”, Zentralblatt fur Chirurgie, No. 28, pp. 1731-1736, 1927 and translation into English.
G. de Takats, “Ambulatory Ligation of the Saphenous Vein”, The Journal of the American Medical Association, vol. 94, No. 16, pp. 1194-1197, Apr. 19, 1930.
G. de Takats et al., “The Injection Treatment of Varicose Veins”, Surgery, Gynecology and Obstetrics, vol. L., No. 3, pp. 545-561, Mar. 1930.
De L'Academie des Sciences, Conformement A Une Decision de L'Academie, pp. 890-892, Jan. 1930 and translation into English.
I.S. Tunick et al., “Sodium Morrhuate as a Sclerosing Agent in the Treatment of Varicose Veins”, Annals of Surgery, vol. XCV, pp. 734-737, 1932.
H. Jausion, “Glycerine Chromee et Sclerose des Ectasies Veineuses”, La Presse Medicale, No. 53, pp. 1061-1063, Jul. 5, 1933.
H. Harkins et al., “Embolism by

Affiliated with

Also associated with

Rating

Injectable microfoam containing a sclerosing agent does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Injectable microfoam containing a sclerosing agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Injectable microfoam containing a sclerosing agent will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4115021